Davis Polk advised the underwriters in the offering, while Jones Day advised EDAP. EDAP TMS S.A. executed its $28 million public offering of 4,150,000 American depositary shares,...
EDAP TMS’s $28 Million Public Offering
Beam Therapeutics’ $300 Million At-The-Market Offering
Davis Polk advised Jefferies, the sales agent, in the transaction. Beam Therapeutics Inc. executed the at-the-market offering of shares of its common stock for up to a...
Charles River Laboratories’ $875 Million Acquisition of Cognate BioServices
Davis Polk and Hannes Snellman advised Charles River Laboratories International on the deal. Weil, Gotshal & Manges advised Charles River Laboratories on the antitrust aspects of...